Identification of immune-activating metabolite for enhancing T cell therapy of cancer

Cancer Commun (Lond). 2021 Jul;41(7):535-537. doi: 10.1002/cac2.12177. Epub 2021 May 18.

Abstract

In this Research Highlight, we summarized the results from a study by Wu et al. published in Nature Cell Biology which uncovered that asparagine (Asn), a non-essential amino acid in mammalians, is able to enhance the TCR-mediated activation and efficacy of CD8+ T cells towards tumour through lymphocyte-specific protein tyrosine kinase (LCK) signalling. This study provides insights into the physiological function of Asn in T cell activation and effector functions, showing the encouraging possibility of key metabolites for empowering cancer immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes* / metabolism
  • Cell- and Tissue-Based Therapy
  • Humans
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / metabolism
  • Neoplasms* / therapy
  • Phosphorylation

Substances

  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)